Existing results indicating similarities in nucleotide/protein sequences among IFITM family members contrast with the functional differences showing that IFITM1 and IFITM3 act in a similar manner but act differently from IFITM2, whose effects on tumor progression and therapeutic efficacy are controversial. Here, IFITM2 is linked to neoplasm.